{"symbol": "APOP", "companyName": "Cellect Biotechnology Ltd.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.cellect.co", "description": "Cellect Biotechnology Ltd is an emerging biotechnology company engaged in developing a novel technology platform known as ApoGraft that selects stem cells in order to improve the safety and efficacy of regenerative medicine and stem cell therapies.", "CEO": "Shai Yarkoni", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}